Skip to content
10-K

Annual Report

SAFECODE DRUG TECHNOLOGIES CORP.

0001144204-13-017087

← back to feed
Filed
Mar 25, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Dec 31, 2012 76.08M sh
Operating Cash Flow FY 2012 · Dec 31, 2012 −$98.14K
Operating Cash Flow FY 2012 · Dec 31, 2012 −$129.27K
Operating Cash Flow FY 2012 · Dec 31, 2011 −$23.91K
Cash And Equivalents FY 2012 · Dec 31, 2012 $0
Cash And Equivalents FY 2012 · Dec 31, 2011 $0
Cash And Equivalents FY 2012 · Dec 31, 2010 $0
Cash And Equivalents FY 2012 · Nov 22, 2010 $0
Stockholders Equity FY 2012 · Dec 31, 2012 $112.66K
Stockholders Equity FY 2012 · Dec 31, 2011 −$50.62K
Stockholders Equity FY 2012 · Dec 31, 2010 −$11.76K
Stockholders Equity FY 2012 · Nov 22, 2010 $0
Current Liabilities FY 2012 · Dec 31, 2012 $61.67K
Current Liabilities FY 2012 · Dec 31, 2011 $70.62K
Total Liabilities FY 2012 · Dec 31, 2012 $61.67K
Total Liabilities FY 2012 · Dec 31, 2011 $70.62K
Current Assets FY 2012 · Dec 31, 2012 $174.33K
Current Assets FY 2012 · Dec 31, 2011 $20K
Total Assets FY 2012 · Dec 31, 2012 $174.33K
Total Assets FY 2012 · Dec 31, 2011 $20K
Net Income FY 2012 · Dec 31, 2012 −$2.06M
Net Income FY 2012 · Dec 31, 2012 −$2.12M
Net Income FY 2012 · Dec 31, 2011 −$41.86K
Net Income FY 2012 · Dec 31, 2010 −$11.76K
Operating Income FY 2012 · Dec 31, 2012 −$2.04M
Operating Income FY 2012 · Dec 31, 2012 −$2.1M
Operating Income FY 2012 · Dec 31, 2011 −$41.86K
Revenue FY 2012 · Dec 31, 2012 $0
Revenue FY 2012 · Dec 31, 2012 $0
Revenue FY 2012 · Dec 31, 2011 $0